EYP-1901 for Retinal Exudative Diseases - Top-Institutions - MDSpire

EYP-1901 for Retinal Exudative Diseases

Updates from the clinical trial program in Wet AMD and DME

  • By

  • Ashkan M. Abbey

  • May 29, 2026

  • 6 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Texas Retina Associates
    Texas Retina Associates

    Dallas, Texas

    Key Differentiators

    • Retina

  • #2

    Retina Vitreous Associates of Florida
    Retina Vitreous Associates of Florida

    Florida, Florida

    Key Differentiators

    • Retina

  • #3

    Palo Alto Medical Foundation; Byers Eye Institute
    Palo Alto Medical Foundation; Byers Eye Institute

    Palo Alto, California

    Key Differentiators

    • Retina

  • #4

    Association for Research in Vision and Ophthalmology
    Association for Research in Vision and Ophthalmology

    Florida, Florida

    Key Differentiators

    • Ophthalmology Research

  • #5

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Key Differentiators

    • Retina

Original Source(s)

EYP-1901 for Retinal Exudative Diseases

  • by Ashkan M. Abbey

  • May 29, 2026

Related Content

Anti-VEGF Gains Ground in PDR

Brolucizumab challenges laser procedure in proliferative diabetic retinopathy management

  • May 28, 2026

  • 4 min
Myopia Management: Treat the Growing Eye, Not Just the Prescription

When to start, what to measure, how to monitor, and when to adjust course

Accelerating Peer Learning in Eye Care

Lumenis launches peer-to-peer learning program aimed at developing practical strategies for modern-day practice

  • May 27, 2026

  • 2 min